Pramod Thekkat

Pramod Thekkat is an accomplished biomedical researcher with extensive experience in immunotherapy and targeted cancer therapy. Currently serving as a Principal Investigator at Synnovation Therapeutics since January 2024, Pramod previously held the role of Senior Scientist at Proteovant Therapeutics from December 2021 to December 2023, and served as a Research Expert at Incyte for over six years. Pramod's expertise encompasses the execution of key experiments for novel target identification, development and optimization of immunoassays, and support for FDA-approved campaigns. Earlier positions include Scientist I at Novartis Institutes for BioMedical Research and roles at Cold Spring Harbor Laboratory and Stanford University, with a solid academic foundation from Western Michigan University where a Master of Science in Biochemistry and Molecular Biology was obtained.